OrthoPediatrics Corp.

NASDAQ:KIDS

Medical - Devices

Healthcare
$31.65 +1.05%

+$0.19 today

Market cap
$826.40M
Beta
1.01
P/E (TTM)
-11.0
EPS (TTM)
-$1.68
52W Low $14.42High $23.70

Volume 0.16M

Average 0.16M

KIDS EBITDA Margin

EBITDA as a percentage of revenue.

OrthoPediatrics Corp.NASDAQ: KIDS

EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026

EBITDA Margin widens to -5.1%

EBITDA Margin was -5.1% in Q1 FY2026, up 3.1 pp from a year earlier. On a trailing-twelve-month basis it was -2.7%, up 3.5 pp year over year. Over 3 fiscal years it widened by 2.1 pp.

Context

  • EBITDA Margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 6 analysts of -1.2% for the fiscal year ending Dec 2026, up from -5.1% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-5.1%-8.3 pp QoQ
Last fiscal yearDec 2025
-5.1%+4.8 pp YoY
LTMMar 2026
-2.7%+3.5 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+3.1 pp+2.6 pp-0.4 pp
1 year+4.8 pp+3.9 pp-0.9 pp
3 years+2.1 pp+11.6 pp+9.6 pp
5 years+19.6 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
-5.1%
Year-over-year change
+4.8pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How KIDS compares with its peers on the latest reported figures

  • KIDS's LTM Mar 2026 EBITDA Margin of -2.7% is the 2nd highest of the 8 companies compared; the peer median is -22.3%.
  • Its year-over-year change of +3.5 pp is the 4th highest of 8, against a peer median of -2.1 pp.
  • Over three fiscal years its change of +2.1 pp compares with a peer median of +41.2 pp.
KIDS Competitors Peer median
EBITDA Margin for KIDS and competitors
Company Period LTM level YoY 3-year change
BVSBioventus Inc.LTM Mar 202617.9% +11.6 pp+41.2 pp
KIDSOrthoPediatrics Corp.LTM Mar 2026-2.7% +3.5 pp+2.1 pp
EOLSEvolus, Inc.LTM Mar 2026-4.6% +6.2 pp+28.7 pp
TOIThe Oncology Institute, Inc.LTM Mar 2026-5.4% +6.2 pp+18.3 pp
TMCITreace Medical Concepts, Inc.LTM Mar 2026-22.3% -4.0 pp+5.3 pp
RXSTRxSight, Inc.LTM Mar 2026-33.9% -19.3 pp+89.0 pp
CBLLCeriBell, Inc.LTM Mar 2026-60.2% -2.1 pp+78.9 pp
LABStandard BioTools Inc.LTM Mar 2026-94.5% -30.2 pp+72.1 pp
Peer median (excluding KIDS) -22.3%-2.1 pp+41.2 pp

Competitors are the stored peer set for KIDS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue98.05M122.29M148.73M204.73M236.35M
Cost of Revenue24.65M31.63M37.48M56.13M63.69M
Gross Profit73.4M90.66M111.25M148.6M172.66M
Gross Margin74.9%74.1%74.8%72.6%73.1%
Research & Development5.54M8.45M10.9M11.03M9.1M
Selling, General & Admin85.73M104M126.12M167.09M192.56M
Operating Expenses91.43M116.06M138M178.12M201.66M
Depreciation & Amortization10.68M13.1M17.39M19.08M21.25M
EBITDA(7.19M)(8.69M)(8.38M)(20.23M)(11.94M)
EBITDA Margin-7.3%-7.1%-5.6%-9.9%-5.1%
Operating Income(18.02M)(25.4M)(26.75M)(29.52M)(29M)
Operating Margin-18.4%-20.8%-18.0%-14.4%-12.3%
Interest Income00198K00
Interest Expense2.25M2.42M02.62M6M
Other Income / Expenses636K21.71M5.44M(12.41M)(10.19M)
Income Before Tax(17.39M)(3.69M)(21.31M)(41.93M)(39.19M)
Pre-Tax Margin-17.7%-3.0%-14.3%-20.5%-16.6%
Income Tax Expense(1.13M)(4.95M)(338K)(4.11M)460K
Net Income(16.26M)1.26M(20.97M)(37.82M)(39.65M)
Net Margin-16.6%1.0%-14.1%-18.5%-16.8%
EPS (Basic)(0.84)0.06(0.92)(1.64)(1.69)
EPS (Diluted)(0.84)0.06(0.92)(1.64)(1.69)
Weighted Avg Shares19.27M20.7M22.68M23.08M23.46M
Weighted Avg Shares (Diluted)19.27M20.95M22.68M23.08M23.46M

OrthoPediatrics Corp.

NASDAQ:KIDS

Intrinsic Alpha fair value

Locked

Current Price

$31.65

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.